City
Epaper

Pharmacopoeia Commission conducts training programme to boost regulation, quality of Ayush drugs

By IANS | Updated: September 13, 2025 11:00 IST

New Delhi, Sep 13 The Pharmacopoeia Commission for Indian Medicine and Homoeopathy has conducted a Capacity-Building Training Programme ...

Open in App

New Delhi, Sep 13 The Pharmacopoeia Commission for Indian Medicine and Homoeopathy has conducted a Capacity-Building Training Programme to enhance regulation and quality of Ayush drugs, the Ministry of Ayush said.

The five-day programme, held from September 8 to 12 in Ghaziabad, aimed to strengthen the regulatory framework, quality assurance, and standardisation processes for Ayurveda, Siddha, Unani, and Homoeopathy drugs.

The training brought together 27 participants from across India, representing regulatory bodies, research councils, pharmaceutical industries, and academic institutions.

The comprehensive sessions were designed to equip Drug Enforcement Officers, Quality Control Personnel, and drug manufacturers with advanced knowledge and hands-on experience in pharmacopoeial standards and Good Manufacturing Practices (GMP).

The technical sessions covered pharmacognostic identification, phytochemical analysis, and GMP compliance, along with hands-on training in the pharmacognosy and chemistry laboratories.

The lectures by several experts focused on shelf-life studies and regulatory frameworks, followed by industry visits to Dr. Willmar Schwabe India (Noida) and Hamdard Laboratories (Ghaziabad), offering real-world exposure.

The sessions included microbiological and pharmacological evaluations, standardisation of metal and mineral drugs, and regulatory aspects. Participants also engaged in laboratory training and visited the on-site herbal garden.

The sessions also featured discussions on NABL accreditation, GMP, and the standardisation of Siddha drugs.

Participants highly appreciated the programme’s unique blend of expert-led lectures, practical laboratory sessions, and field visits.

The training significantly contributed to enhancing their understanding of pharmacopoeial standards, GMP, and regulatory compliance, thereby reinforcing the national commitment to ensuring the safety, efficacy, and quality of ASU&H drugs.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

EntertainmentUnpredictable, Unforgettable: Performances That Cement Divyenndu’s Range as an Actor

InternationalPM Modi arrives in Addis Ababa, received by Ethiopian counterpart at airport

Other SportsIPL 2026 Auction: CSK spend record 14.2 Cr each for Prashant Veer, Kartik Sharma; Auqib Dar goes to DC for 8.4 Cr in uncapped category

AurangabadJaganmata Sharada elocution contest begins

HealthWalking After Dinner: When, How, and How Much to Walk for Better Digestion

Health Realted Stories

HealthAyush Expo to anchor second WHO Global Traditional Medicine Summit

HealthIndia records 1,13,440 dengue cases, 94 deaths till November: Govt

HealthINST researchers develop new nanoparticle-based multifunctional therapy for Alzheimer’s

LifestyleWeight Loss: How Celebrities Regain Their Figures in Months After Giving Birth

HealthIIT Delhi, AIIMS’s new ingestible device can collect microbial samples from small intestine